Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Memphasys Ltd ( (AU:MEM) ) has shared an update.
Memphasys Ltd has announced the issuance of 45,115,338 unquoted securities, specifically options expiring on November 5, 2026. This move is part of previously announced transactions and is not intended to be quoted on the ASX, potentially impacting the company’s financial strategy and stakeholder interests.
More about Memphasys Ltd
Memphasys Ltd operates in the biotechnology industry, focusing on reproductive biotechnology solutions. The company is known for developing products that enhance fertility outcomes, targeting both clinical and consumer markets.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$10.46M
See more insights into MEM stock on TipRanks’ Stock Analysis page.